Mobile

Safety and Immunogenicity of Repeated Exposure to an Adjuvanted Quadrivalent Subunit Influenze Virus Vaccine Compared to Non-Adjuvanted Comparator Influenza Vaccine in Children Vaccinated in Trial V11...

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-002599-95

Safety and Immunogenicity of Repeated Exposure to an Adjuvanted Quadrivalent Subunit Influenze Virus Vaccine Compared to Non-Adjuvanted Comparator Influenza Vaccine in Children Vaccinated in Trial V118_05

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Primary Immunogenicity Objective: To evaluate the antibody responses to homologous (CBER criteria) influenza strains post vaccination with aQIV or a non-adjuvanted comparator influenza vaccine in children previously vaccinated in parent trial V118_05. Primary Safety Objective: To evaluate the safety of revaccination of aQIV or nonadjuvanted comparator vaccine in children previously vaccinated in parent trial V118_05

Critère d'inclusion

  • Prophylaxis for influenza virus

Liens